ADIPOQ and plasma cell myeloma: In contrast, addition of a neutralizing antibody to TNF‐α to myeloma/BMAd co‐cultures had no effect on viability (Supplemental Fig. S6B) but blocked the suppression of adiponectin and prevented the reduction in BMAd number (Fig. 7I and Supplemental Fig. S6C).